Citation: S. Hagg et al., Influence of gender and oral contraceptives on CYP2D6 and CY2ZC19 activityin healthy volunteers, BR J CL PH, 51(2), 2001, pp. 169-173
Citation: S. Hagg et al., Repeated episodes of hypothermia in a subject treated with haloperidol, levomepromazine, olanzapine, and thioridazine, J CL PSYCH, 21(1), 2001, pp. 113-115
Authors:
Spigset, O
Hagg, S
Stegmayr, B
Dahlqvist, R
Citation: O. Spigset et al., Citalopram pharmacokinetics in patients with chronic renal failure and theeffect of haemodialysis, EUR J CL PH, 56(9-10), 2000, pp. 699-703
Authors:
Spigset, O
Hagg, S
Soderstrom, E
Dahlqvist, R
Citation: O. Spigset et al., The paraxanthine : caffeine ratio in serum or in saliva as a measure of CYP1A2 activity: when should the sample be obtained?, PHARMACOGEN, 9(3), 1999, pp. 409-412
Authors:
Spigset, O
Andersen, T
Hagg, S
Mjorndal, T
Citation: O. Spigset et al., Enhanced platelet serotonin 5-HT2A receptor binding in anorexia nervosa and bulimia nervosa, EUR NEUROPS, 9(6), 1999, pp. 469-473
Authors:
Hagg, S
Spigset, O
Edwardsson, H
Bjork, H
Citation: S. Hagg et al., Prolonged sedation and slowly decreasing clozapine serum concentrations after an overdose, J CL PSYCH, 19(3), 1999, pp. 282-284
Authors:
Spigset, O
Hagg, S
Soderstrom, E
Dahlqvist, R
Citation: O. Spigset et al., Lack of correlation between fluvoxamine clearance and CYP1A2 activity as measured by systemic caffeine clearance, EUR J CL PH, 54(12), 1999, pp. 943-946